Free Trial

ImmuCell (ICCC) SEC Filings & 10K Form

ImmuCell logo
$5.39 -0.11 (-2.00%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$4.75 -0.64 (-11.87%)
As of 08:56 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ImmuCell SEC Filings

DateFilerForm TypeView
04/08/2025
3:05 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2025
3:15 PM
Fiori Timothy C (Reporting)
ImmuCell (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/16/2025
3:05 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
6:10 AM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
3:05 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:05 PM
ImmuCell (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/24/2024
10:55 AM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2024
7:29 AM
ImmuCell (Issuer)
Rosgen Steven T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
7:29 AM
Gathagan Bryan K. (Reporting)
ImmuCell (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
7:30 AM
ImmuCell (Issuer)
Tomsche David Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
7:30 AM
Basse Gloria F (Reporting)
ImmuCell (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
7:31 AM
ImmuCell (Issuer)
Wainman Paul R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
12:49 PM
ImmuCell (Subject)
SRK FUND I, LP (Filed by)
Form SCHEDULE 13D/A
08/30/2024
11:25 AM
ImmuCell (Issuer)
Tomsche David Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:32 PM
ImmuCell (Subject)
Knudsen Ejnar A III (Filed by)
Form SC 13D
08/26/2024
2:00 PM
ImmuCell (Issuer)
Tomsche David Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
12:05 PM
ImmuCell (Issuer)
Tomsche David Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
12:04 PM
ImmuCell (Issuer)
Tomsche David Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:05 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
12:38 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
10:33 AM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
6:49 AM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
3:50 PM
ImmuCell (Subject)
SRK FUND I, LP (Filed by)
Form SCHEDULE 13D
05/14/2024
3:05 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:06 PM
ImmuCell (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
8:00 AM
ImmuCell (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:ICCC) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners